Skip to main content
. 2007 Dec;3(6):847–853. doi: 10.2147/ndt.s1636

Table 1.

Comparing the BOLDER studies

BOLDER I
BOLDER II
Placebo Seroquel-300 Seroquel-600 Placebo Seroquel-300 Seroquel-600
N 181 181 180 168 172 169
DSM-IV diagnosis
BP 1 (%) 66.3 67.4 67.1 68.3 67.1 66.9
BP II (%) 33.7 32.6 32.9 31.7 32.9 33.1
RCBD 20.7 24.4 18.2 32.9 28.4 30.5
mean age 38.3 36.6 37.3 37.7 37.2 38.2
sex (%)
male 37.9 45.9 41.8 39.8 44.5 45
female 62.1 54.1 58.2 60.2 55.5 55
baseline scores
MADRS 30.6 30.4 30.3 29.6 31.1 29.9
HAM-D 24.6 24.5 24.7 24.3 24.9 24.3
CGI 4.4 4.4 4.5 4.5 4.6 4.4
Mean change in score
MADRS −10.26 −16.39 −16.73 −11.93 −16.94 −16
HAM-D −8.54 −13.38 −13.84 −9.92 −13.81 −12.97
CGI 2.97 2.27 2.37 2.88 2.28 2.29
Response rates 36.10% 58% 58% 44.70% 60.00% 58.30%
Remission rates 28.40% 52.90% 52.90% 37.30% 51.60% 52.30%
Effect size in BP I 0.91 1.09 0.67 0.51
Effect size in BP II 0.28 0.39 0.56 0.64

Abbreviations: BP, bipolar; CGI, Clinical Global Impression; DSM-IV, Diagnostic and Statistical Manual of Mental Disorders, fourth edition; HAM-D, Hamilton depression rating scale; MADRS, Montgomery-Åsberg Depression Rating Scale scores; RCBD, rapid cycling bipolar disorder.